Sept. 11, 2013
/PRNewswire/ -- Euclid Systems Corporation today announced the signing of a cooperation agreement with Wenzhou Medical University Eye Hospital.
"Thanks to a number of studies showing the ability of Euclid's Emerald™ brand Ortho-K lens to retard the progression (worsening) of myopia in children, the Chinese population are accepting this treatment in increasing numbers," stated Michael A Ross, MD, President and COO of Euclid. "This strategic partnership with the Wenzhou Medical University will further enhance Euclid's reputation as the leading provider of Ortho-K lenses in
Through this cooperative agreement, Euclid will support and assist the University in several areas, including the training of new Optometrists and Ophthalmologists in the fitting and use of Orthokeratology lenses, as well as to study of the advantages of Orthokeratology for the prevention of the progression of myopia (nearsightedness) and for treatment for high myopes (extremely nearsighted) patients. Wenzhou University will support Euclid by presenting at Ophthalmology meetings and conferences, by being a resource for prescribing doctors throughout
, and by promoting the health benefits and care standards for Orthokeratology. Additionally the University will work with Euclid to open an Ortho-K Trial Center on the hospital grounds as a model for prescribing doctors in
About Wenzhou Medical University Eye Hospital.
The Affiliated Eye Hospital of Wenzhou Medical University is a class-A specialized eye hospital and is famous for its "
" of combination of optometry and ophthalmology. The eye hospital, the chairman unit of the Chinese Optometry Association, leads the development of optometry in China. It is also the National Optometry Center of Ministry of Public Health P.R.China and the chairman unit of International Academy Orthokeratology Asia, playing a leading role in the training, discipline development, security monitoring and organization development of Orthokeratology in
About Euclid Systems Corporation.
Euclid, founded in 1995, first developed and brought to market a standardized Ortho-K lens design and manufacturing process. Euclid was the first company to apply for FDA approval, and the Emerald lens was approved by the FDA in 2004. The Emerald lens has obtained regulatory approval from the appropriate governing bodies in multiple international markets. Additionally, Euclid is involved in a number of research projects investigating corneal stabilization.
SOURCE Euclid Systems Corporation